Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Association between serum IgG concentrations and the incidence of infections in patients with chronic lymphocytic leukemia and secondary immunodeficiency under treatment with Privigen
CONCLUSION: This analysis confirms the association of serum IgG trough levels with the incidence of infections and highlights the importance of careful monitoring of IgG levels during treatment of secondary immunodeficiencies in CLL patients.PMID:38577752 | DOI:10.5414/CP204473 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - April 5, 2024 Category: Drugs & Pharmacology Authors: Burkhard Otremba Ferdinand Haslbauer Marcel Reiser Rudolf Weide Michael Obermeier Dietmar Pfr ünder Source Type: research
Reported Case Report of Recovery from Rabies Using Intrathecal Rabies Immune Globulin was Flawed - ADDENDUM
Can J Neurol Sci. 2024 Apr 4:1. doi: 10.1017/cjn.2024.39. Online ahead of print.NO ABSTRACTPMID:38572615 | DOI:10.1017/cjn.2024.39 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - April 4, 2024 Category: Neurology Authors: Alan C Jackson Charles E Rupprecht Reeta S Mani Nidia Ar échiga-Ceballos Darryn L Knobel Source Type: research
Reported Case Report of Recovery from Rabies Using Intrathecal Rabies Immune Globulin was Flawed - ADDENDUM
Can J Neurol Sci. 2024 Apr 4:1. doi: 10.1017/cjn.2024.39. Online ahead of print.NO ABSTRACTPMID:38572615 | DOI:10.1017/cjn.2024.39 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - April 4, 2024 Category: Neurology Authors: Alan C Jackson Charles E Rupprecht Reeta S Mani Nidia Ar échiga-Ceballos Darryn L Knobel Source Type: research
Reported Case Report of Recovery from Rabies Using Intrathecal Rabies Immune Globulin was Flawed - ADDENDUM
Can J Neurol Sci. 2024 Apr 4:1. doi: 10.1017/cjn.2024.39. Online ahead of print.NO ABSTRACTPMID:38572615 | DOI:10.1017/cjn.2024.39 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - April 4, 2024 Category: Neurology Authors: Alan C Jackson Charles E Rupprecht Reeta S Mani Nidia Ar échiga-Ceballos Darryn L Knobel Source Type: research
Reported Case Report of Recovery from Rabies Using Intrathecal Rabies Immune Globulin was Flawed - ADDENDUM
Can J Neurol Sci. 2024 Apr 4:1. doi: 10.1017/cjn.2024.39. Online ahead of print.NO ABSTRACTPMID:38572615 | DOI:10.1017/cjn.2024.39 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - April 4, 2024 Category: Neurology Authors: Alan C Jackson Charles E Rupprecht Reeta S Mani Nidia Ar échiga-Ceballos Darryn L Knobel Source Type: research
Reported Case Report of Recovery from Rabies Using Intrathecal Rabies Immune Globulin was Flawed - ADDENDUM
Can J Neurol Sci. 2024 Apr 4:1. doi: 10.1017/cjn.2024.39. Online ahead of print.NO ABSTRACTPMID:38572615 | DOI:10.1017/cjn.2024.39 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - April 4, 2024 Category: Neurology Authors: Alan C Jackson Charles E Rupprecht Reeta S Mani Nidia Ar échiga-Ceballos Darryn L Knobel Source Type: research
